Holdsworth-Carson SJ, et al. Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues. Mol Hum Reprod. 2014;20(3):250–9.

CAS  PubMed  Google Scholar 

Jamaluddin MFB, Nahar P, Tanwar PS. Proteomic characterization of the extracellular matrix of human uterine fibroids. Endocrinology. 2018;159(7):2656–69.

CAS  PubMed  Google Scholar 

Stewart EA, Nowak RA. Uterine fibroids: hiding in plain sight. Physiology (Bethesda). 2022;37(1):16–27.

CAS  PubMed  Google Scholar 

Rogers R, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 2008;198(4):474.e1-11.

PubMed  Google Scholar 

Islam MS, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59–85.

CAS  PubMed  Google Scholar 

Marsh EE, et al. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Womens Health (Larchmt). 2018;27(11):1359–67.

PubMed  Google Scholar 

Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–12.

CAS  PubMed  Google Scholar 

Flynn M, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–64.

PubMed  Google Scholar 

Laughlin-Tommaso SK, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018;25(5):483–92.

PubMed  PubMed Central  Google Scholar 

Laughlin-Tommaso SK, et al. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study. Menopause. 2020;27(1):33–42.

PubMed  PubMed Central  Google Scholar 

Laughlin-Tommaso SK, et al. Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause. 2016;23(2):121–8.

PubMed  PubMed Central  Google Scholar 

Tuesley KM, et al. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol. 2020;223(5):723.e1-723.e16.

PubMed  Google Scholar 

Farland LV, et al. Hysterectomy with and without oophorectomy, tubal ligation, and risk of cardiovascular disease in the nurses’ health study II. J Womens Health (Larchmt). 2023;32(7):747–56.

PubMed  Google Scholar 

Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13–24.

PubMed  Google Scholar 

Darnell JE Jr. STATs and gene regulation. Science. 1997;277(5332):1630–5.

CAS  PubMed  Google Scholar 

Harrison DA. The Jak/STAT pathway. Cold Spring Harb Perspect Biol. 2012;4(3):a011205.

PubMed  PubMed Central  Google Scholar 

Liu J, Wang F, Luo F. The Role of JAK/STAT pathway in fibrotic diseases: molecular and cellular mechanisms. Biomolecules. 2023;13(1):119.

CAS  PubMed  PubMed Central  Google Scholar 

Thomas SJ, et al. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015;113(3):365–71.

CAS  PubMed  PubMed Central  Google Scholar 

Malik M, et al. Cross-talk between Janus kinase-signal transducer and activator of transcription pathway and transforming growth factor beta pathways and increased collagen1A1 production in uterine leiomyoma cells. F S Sci. 2020;1(2):206–20.

PubMed  Google Scholar 

Huang D, et al. Inhibiting effect of miR-29 on proliferation and migration of uterine leiomyoma via the STAT3 signaling pathway. Aging (Albany NY). 2022;14(3):1307–20.

CAS  PubMed  Google Scholar 

Plimack ER, et al. AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors. Oncologist. 2013;18(7):819–20.

PubMed  PubMed Central  Google Scholar 

Hedvat M, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell. 2009;16(6):487–97.

CAS  PubMed  PubMed Central  Google Scholar 

Hassan MH, et al. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008;199(2):156.e1-8.

PubMed  Google Scholar 

Tsuiji K, et al. Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice. Tohoku J Exp Med. 2010;222(1):55–61.

PubMed  Google Scholar 

Fritsch M, et al. Application of a patient derived xenograft model for predicative study of uterine fibroid disease. PLoS One. 2015;10(11):e0142429.

PubMed  PubMed Central  Google Scholar 

Borahay MA, et al. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015;213(2):196.e1-8.

CAS  PubMed  Google Scholar 

Suzuki Y, et al. Establishment of a novel mouse xenograft model of human uterine leiomyoma. Sci Rep. 2018;8(1):8872.

PubMed  PubMed Central  Google Scholar 

Malik M, Britten J, Catherino WH. Development and validation of hormonal impact of a mouse xenograft model for human uterine leiomyoma. Reprod Sci. 2020;27(6):1304–17.

CAS  PubMed  Google Scholar 

Corachán A, et al. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2020;113(1):205-216.e4.

PubMed  Google Scholar 

Sápi J, et al. Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy. PLoS One. 2015;10(11):e0142190.

PubMed  PubMed Central  Google Scholar 

McFarland BC, et al. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. Mol Cancer Ther. 2011;10(12):2384–93.

CAS  PubMed  PubMed Central  Google Scholar 

Xin H, et al. Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480. Cancer Res. 2011;71(21):6601–10.

CAS  PubMed  PubMed Central  Google Scholar 

Gritsina G, et al. Targeted Blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth. Mol Cancer Ther. 2015;14(4):1035–47.

CAS  PubMed  PubMed Central  Google Scholar 

Jones CP, Boyd KL, Wallace JM. Evaluation of mice undergoing serial oral gavage while awake or anesthetized. J Am Assoc Lab Anim Sci. 2016;55(6):805–10.

PubMed  PubMed Central  Google Scholar 

Jayes FL, et al. Evidence of biomechanical and collagen heterogeneity in uterine fibroids. PLoS One. 2019;14(4):e0215646.

CAS  PubMed  PubMed Central  Google Scholar 

Huynh J, et al. Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. Nat Rev Cancer. 2019;19(2):82–96.

CAS  PubMed  Google Scholar 

Britten JL, et al. Three-dimensional human leiomyoma xenografts induce angiogenesis by inducing hypoxia inducible factor-1 alpha. F S Sci. 2021;2(2):219–27.

PubMed  Google Scholar 

Cetin E, Al-Hendy A, Ciebiera M. Non-hormonal mediators of uterine fibroid growth. Curr Opin Obstet Gynecol. 2020;32(5):361–70.

PubMed  PubMed Central  Google Scholar 

Peddada SD, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887–92.

CAS  PubMed  PubMed Central  Google Scholar 

Yan S, Li Z, Thiele CJ. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. Oncotarget. 2013;4(3):433–45.

PubMed  PubMed Central  Google Scholar 

Couto JP, et al. AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. PLoS One. 2012;7(10):e46869.